SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 94 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,125 | -11.8% | 1,822 | +0.1% | 0.00% | – |
| Q2 2023 | $47,747 | +103697.8% | 1,821 | +1.2% | 0.00% | – |
| Q1 2023 | $46 | -2.1% | 1,800 | 0.0% | 0.00% | – |
| Q4 2022 | $47 | -99.9% | 1,800 | -0.4% | 0.00% | – |
| Q3 2022 | $43,000 | -2.3% | 1,807 | +1.5% | 0.00% | – |
| Q2 2022 | $44,000 | -10.2% | 1,780 | +107.0% | 0.00% | – |
| Q1 2022 | $49,000 | -31.0% | 860 | -32.8% | 0.00% | -100.0% |
| Q4 2021 | $71,000 | -41.8% | 1,280 | -33.3% | 0.00% | 0.0% |
| Q3 2021 | $122,000 | -22.8% | 1,920 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $158,000 | +43.6% | 1,920 | +28.0% | 0.00% | 0.0% |
| Q1 2021 | $110,000 | +0.9% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $109,000 | +127.1% | 1,500 | +50.0% | 0.00% | – |
| Q3 2020 | $48,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |